Business Description
Protara Therapeutics is a New York-based medical research company focused on developing new treatments for cancer and rare conditions. Its most advanced candidate, TARA-002, is a cell-based therapy currently being tested in Phase II trials for bladder cancer and a rare condition affecting the lymphatic system. The company is also working on an intravenous form of choline chloride to support patients who rely on IV nutrition.
